Diet Patterns, the Gut Microbiome, and Alzheimer's Disease

Area of Science:

• Neuroscience
• Microbiology
• Nutrition Science

Background:

• The gut-brain axis involves bidirectional communication, with gut microbiome alterations linked to Alzheimer's disease (AD) pathogenesis.
• Gut dysbiosis and its metabolites (e.g., TMAO, LPS, SCFAs) may drive neuroinflammation and amyloidosis, contributing to AD progression.
• Emerging research suggests the gut mycobiome may also impact AD pathology.

Purpose of the Study:

• To explore the role of the gut microbiome and its metabolites in Alzheimer's disease (AD).
• To investigate the potential of dietary interventions in modulating the gut microbiome for AD risk reduction.
• To highlight the need for human intervention studies on diet, gut microbiome, and AD.

Main Methods:

• Review of existing literature on the gut-brain axis, gut microbiome, mycobiome, and Alzheimer's disease.
• Analysis of proposed mechanisms involving gut microbiota metabolites in neuroinflammation and amyloidosis.
• Discussion of the impact of diet on gut microbiome composition and its relevance to AD.

Main Results:

• Gut dysbiosis is implicated in initiating and prolonging neuroinflammatory processes in AD.
• Gut microbiota metabolites are suggested to mediate systemic inflammation and intracerebral amyloidosis.
• Diet accounts for significant variation in the gut microbiome, indicating its modulatory potential.

Conclusions:

• Dietary patterns, rather than isolated nutrients, may be more predictive of real-world effects on the gut microbiome and AD risk.
• While animal and experimental studies show promise, human dietary intervention data for AD prevention is currently lacking.
• Well-designed human intervention studies are crucial to validate dietary strategies for AD prevention via gut microbiome modulation.